Challenge Intelligent Manufacturing Secures Multi-Million RMB Angel Round Financing

Beijing, October 10, 2024 – Challenge Intelligent Manufacturing (Beijing) Technology Co., Ltd. has successfully completed a tens of millions of RMB angel round of financing. The round was led by Huatai GenScript, Tsing Innovation Capital, and Dao Capital, with Index Capital serving as the exclusive financial advisor.

Specializing in advanced membrane filtration systems for the biopharmaceutical industry, Challenge Intelligent Manufacturing has been at the forefront of innovation since its inception. The company designs, manufactures, and services a broad range of filtration products, from laboratory-scale，pilot scale to large-scale production systems. These solutions are tailored to meet the evolving needs of the biopharmaceutical sector and have been successfully commercialized for diverse applications. Among its key innovations is a fully automated tangential flow filtration (TFF) system, which operates without manual intervention, addressing a significant gap in both domestic and international markets.

The company adheres to the guiding philosophy of "Crafting Excellence, Becoming Outstanding," prioritizing the creation of high-quality products, the development of exceptional talent, and providing outstanding customer service. Its products are widely used across critical biopharmaceutical fields, including antibody production, vaccines, nucleic acid drugs, cell therapy, and gene therapy.

Challenge Intelligent Manufacturing has established strategic partnerships with industry leaders such as GenScript, WuXi Biologics, BeiGene, Chia Tai Tianqing, Innovent Biologics, and China National Biotech Group. These partnerships, along with the company’s commitment to domestic substitution and international expansion, have fueled its rapid growth and enhanced its presence in global markets.

With this new round of financing, Challenge IM plans to accelerate its research and development efforts, further enhance its product portfolio, and expand its market reach. The company is poised to continue its rapid growth and strengthen its position as a key player in the biopharmaceutical sector.

As Challenge Intelligent Manufacturing continues to invest in cutting-edge technologies, it is well-positioned to meet the growing demands of the biopharmaceutical industry and contribute to advancements in global life sciences.